The IRS is sending more than 20,000 rejection letters to taxpayers who wrongly claimed a pandemic-era tax break as the agency continues its crackdown on “dubious” filings.
Created to support small businesses during the Covid-19 pandemic, the employee retention credit, or ERC, is worth thousands of dollars per eligible employee. However, the tax break sparked a wave of companies pushing small businesses to wrongly claim the credit — and the agency temporarily stopped processing new filings in September amid a “surge of questionable claims.”
“With the aggressive marketing we saw with this credit, it’s not surprising that we’re seeing claims that clearly fall outside of the legal requirements,” IRS Commissioner Danny Werfel said in a statement Wednesday.
More from Personal Finance:
Supreme Court case on ‘income’ could have major implications for taxpayers
Credit card debt is ‘the biggest threat to building wealth,’ poll finds
Job data suggests ‘soft landing’ is increasingly likely, economists say
Starting this week, ineligible taxpayers will start receiving copies of Letter 105 C for disallowed claims. Later this month, the IRS will unveil a “voluntary disclosure program” for taxpayers who wrongly claimed the credit. The agency is rejecting filings from entities that didn’t exist or didn’t have paid employees during the eligibility period.
“The action we are taking today is part of an initial set of steps in our compliance work in this area,” Werfel said. “More letters will be going out in the near future, including both disallowance letters and letters seeking the return of funds erroneously claimed and received.”
The announcement comes less than two months since the IRS unveiled a special withdrawal process for small businesses that wrongly claimed the credit to avoid repayment, interest and penalties.
Don’t miss these stories from CNBC PRO:
- Saudi Arabia is struggling to boost oil prices, raising possibility of supply war with U.S.
- Here’s where to invest $250,000 for the next 5 years
- Citi is so bullish on this biotech stock it gives it 800% potential upside
- ‘It’s beginning to look a lot like VIX-mas.’ What Wall Street’s fear gauge is saying right now